Prevalencija pseudoeksfolijativnog sindroma i moguća udruženost sa sistemskim oboljenjima kod bolesnika predviđenih za hirurgiju katarakte u Vojnomedicinskoj akademiji u Beogradu
Sažetak
Uvod/Cilj. Pseudoeksfolijativni sindrom (pseudoexfoliation syndrome – PEX) je starosni sistemski degenerativni poremećaj koji karakteriše produkcija i progresivna akumulacija vanćelijskog vlaknastog eozinofilnog materijala na spoljašnjim segmentima oka. Cilj ove studije bio je da ispita određene kliničke aspekte PEX, kao što su: učestalost PEX, pseudoeksfolijativni glaukom (PEXG), intraokularni pritisak (IOP), tipovi katarakte i moguća vezu PEX-a sa sistemskim bolestima. Metode. Svi bolesnici (n = 674) obuhvaćeni studijom detaljno su oftalmološki pregledani, uključujući pregled na biomikroskopu sa procepnom lampom, pre i posle midrijaze, merenje IOP i pregled očnog dna. Bolesnici su bili podeljeni u dve grupe: sa PEX-om i bez PEX-a. Rezultati. Ukupna prevalencija PEX-a bila je 17,5% (118 bolesnika). Prosečna starost bolesnika sa PEX-a bila je (79,7 ± 6,1 godina), što je statistički značajno više u odnosu na bolesnike bez PEX-a (73,5 ± 9,1 godina). Nađeno je da prevalencija PEX-a raste sa starenjem, od 7,3% u sedmoj deceniji života do 27% kod starijih od 80 godina (p < 0,001). Učestalost pojedinih tipova katarakte kod bolesnika sa PEX-om bila je: maturna kod 40,7%, mešovita kod 30,5%, nuklearna kod 25,4%, kortikalna kod 1,7% i hipermaturna kod 1,7% bolesnika. Od 118 bolesnika sa PEX, 44 (37,2%) imalo je glaukom. Vrednosti IOP kod bolesnika sa PEX-om (bez glaukoma) bile su 17,8 ± 3,2 mmHg, što je statistički značajno više (p = 0,000) u odnosu na 15,8 ± 2,8 mmHg kod bolesnika bez PEX (bez glaukoma). Prevalencija koronarne bolesti bila je statistički značajno viša kod bolesnika sa PEX. Zaključak. PEX je čest kod bolesnika sa kataraktom u našoj populaciji. On predstavlja jedan od glavnih rizika od pojave glaukoma, udružen je sa ishemijskom bolešću srca, kao i intraoperativnim i postoperativnim problemima u hirurgiji katarakte.
Reference
Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseu-doexfoliation syndrome. Am J Ophthalmol 2006; 141(5): 921−37.
Schlotzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a sys-temic disorder. Arch Ophthalmol 1992; 110(12): 1752−6.
Konstas AG, Tsironi S, Ritch R. Current concepts in the patho-genesis and management of exfoliation syndrome and exfo-liative glaucoma. Comp Ophthalmol Update 2006; 7(3): 131−41.
Belovay GW, Varma DK, Ahmed II. Cataract surgery in pseudo-exfoliation syndrome. Curr Opin Ophthalmol 2010; 21(1): 25−34.
Shastri L, Vasavada A. Phacoemulsification in Indian eyes with pseudoexfoliation syndrome. J Cataract Refract Surg 2001; 27(10): 1629−37.
Streeten BW, Li ZY, Wallace RN, Eagle RC, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992; 110(12): 1757−62.
Schlötzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a sys-temic disorder. Arch Ophthalmol 1992; 110(12): 1752−6.
Sekeroglu MA, Bozkurt B, Irkec M, Ustunel S, Orhan M, Saracbasi O. Systemic associations and prevalence of exfoliation syn-drome in patients scheduled for cataract surgery. Eur J Oph-thalmol 2008; 18(4): 551−5.
Andrikopoulos GK, Mela EK, Georgakopoulos CD, Papadopoulos GE, Damelou AN, Alexopoulos DK, et al. Pseudoexfoliation syndrome prevalence in Greek patients with cataract and its association to glaucoma and coronary artery disease. Eye (Lond) 2009; 23(2): 442−7.
Ritland JS, Egge K, Lydersen S, Juul R, Semb SO. Exfoliative glau-coma and primary open-angle glaucoma: associations with death causes and comorbidity. Acta Ophthalmol Scand 2004; 82(4): 401−4.
Wålinder PE, Olivius EO, Nordell SI, Thorburn WE. Fibrinoid reaction after extracapsular cataract extraction and relationship to exfoliation syndrome. J Cataract Refract Surg 1989; 15(5): 526−30.
Bojić L, Ermacora R, Polić S, Ivanisević M, Mandić Z, Rogosić V, et al. Pseudoexfoliation syndrome and asymptomatic myocardial dysfunction. Graefes Arch Clin Exp Ophthalmol 2005; 243(5): 446−9.
Cahill M, Early A, Stack S, Blayney A, Eustace P. Pseudoexfolia-tion and sensorineural hearing loss. Eye 2002; 16(3): 261−6.
Mitchell P, Wang JJ, Smith W. Association of pseudoexfoliation syndrome with increased vascular risk. Am J Ophthalmol 1997; 124(5): 685−7.
Schumacher S, Schlötzer-Schrehardt U, Martus P, Lang W, Naumann GO. Pseudoexfoliation syndrome and aneurysms of the ab-dominal aorta. Lancet 2001; 357(9253): 359−60.
Linnér E, Popovic V, Gottfries CG, Jonsson M, Sjögren M, Wallin A. The exfoliation syndrome in cognitive impairment of cere-brovascular or Alzheimer's type. Acta Ophthalmol Scand 2001; 79(3): 283−5.
Young AL, Tang WW, Lam DS. The prevalence of pseudoexfo-liation syndrome in Chinese people. Br J Ophthalmol 2004; 88(2): 193−5.
Kaljurand K, Puska P. Exfoliation syndrome in Estonian pa-tients scheduled for cataract surgery. Acta Ophthalmol Scand 2004; 82(3 Pt 1): 259−63.
Teshome T, Regassa K. Prevalence of pseudoexfoliation syn-drome in Ethiopian patients scheduled for cataract surgery. Acta Ophthalmol Scand 2004; 82(3 Pt 1): 254−8.
Forsius H. Exfoliation syndrome in various ethnic populations. Acta Ophthalmol Suppl 1988; 184: 71−85.
Hietanen J, Kivelä T, Vesti E, Tarkkanen A. Exfoliation syn-drome in patients scheduled for cataract surgery. Acta Oph-thalmol (Copenh) 1992; 70(4): 440−6.
Kozobolis VP, Papatzanaki M, Vlachonikolis IG, Pallikaris IG, Tsambarlakis IG. Epidemiology of pseudoexfoliation in the is-land of Crete (Greece). Acta Ophthalmol Scand 1997; 75(6): 726−9.
Morreno-Montanes J, Paredes AA, Garcia CS. Prevalence of pseu-doexfoliation syndrome in the northwest of Spain. Acta Oph-thalmol (Copenh) 1989; 67(4): 383−5.
Yalaz M, Othman I, Nas K, Eroğlu A, Homurlu D, Cikintas Z, et al. The frequency of pseudoexfoliation syndrome in the eastern Mediterranean area of Turkey. Acta Ophthalmol (Copenh) 1992; 70(2): 209−13.
Krishnadas R, Nirmalan PK, Ramakrishnan R, Thulasiraj RD, Katz J, Tielsch JM, et al.. Pseudoexfoliation in a rural population of southern India: the Aravind Comprehensive Eye Survey. Am J Ophthalmol 2003; 135(6): 830−7.
Kozart DM, Yanoff M. Intraocular pressure status in 100 con-secutive patients with exfoliation syndrome. Ophthalmology 1982; 89(3): 214−8.
Ritch R. Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma. J Glaucoma 1994; 3(2): 176−7.
Netland PA, Ye H, Streeten BW, Hernandez MR. Elastosis of the lamina cribrosa in pseudoexfoliation syndrome with glaucoma. Ophthalmology 1995; 102(6): 878−86.
Psilas KG, Stefaniotou MJ, Aspiotis MB. Pseudoexfoliation syn-drome and diabetes mellitus. Acta Ophthalmol (Copenh) 1991; 69(5): 664−6.
Wood SD, Asefzadeh B, Fisch B, Jiwani A, Lee RK, Conlin PR, et al. The relationship between diabetes mellitus and exfoliation syndrome in a United States Veterans Affairs population: a case-control study. J Glaucoma 2011; 20(5): 278−81.
